Loading clinical trials...
Loading clinical trials...
This phase Ib study investigates the safety and efficacy of performing a retinal vein cannulation with recombinant tissue Plasminogen Activator infusion into a retinal vein with the help of an updated...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
NCT05476926 · Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, and more
NCT01295112 · Non-Ischemic Central Retinal Vein Occlusion
NCT04667910 · Central Retinal Vein Occlusion
NCT06708637 · Age-Related Macular Degeneration, Branch Retinal Vein Occlusion with Macular Edema, and more
NCT00566761 · Macular Edema, Central Retinal Vein Occlusion
Universitaire Ziekenhuizen Leuven
Leuven
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions